A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer (HGCSG1503): Analysis of cases of prior regorafenib.

Atsushi Ishiguro,Satoshi Yuki,Hiroshi Nakatsumi,T. Saiki,Yasushi Tsuji,Kazuteru Hatanaka,Hiroki Yoshita,Shinya Minami,Tomoyuki Ohta,Kazunori Eto,Junta Nakajima,Michio Nakamura,Kazuhiro Suzuki,Masahiko Koike,Kanji Kato,Miki Tateyama,Chiaki Asada,Mari Sekiguchi,Yuh Sakata,Yoshito Komatsu

A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer (HGCSG1503): Analysis of cases of prior regorafenib.

2018

832Background: The J003 trial and RECOURSE trial revealed the safety and efficacy of TAS-102 for patients with metastatic colorectal cancer (mCRC). In March 2014, TAS-102 was approved in Japan. How...

Keywords:

Regorafenib
Retrospective cohort study
Physical therapy
Colorectal cancer
Medicine
Oncology
Internal medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations